VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Novo Nordisk A/S vs TransUnion
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Novo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisTransUnion
TRU · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 61 / 100 for TransUnion).
- Segment focus: Novo Nordisk A/S has 3 segments (71.1% in Diabetes care); TransUnion has 4 segments (34.2% in U.S. Markets - Financial Services).
- Moat breadth: Novo Nordisk A/S has 5 moat types across 3 domains; TransUnion has 8 across 4.
Primary market context
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
TransUnion
U.S. Markets - Financial Services
U.S. consumer credit bureau data & risk analytics for lenders
United States
B2B (banks, lenders, fintechs, mortgage/auto originators)
Consumer reporting agency & decisioning analytics provider
34.2%
Side-by-side metrics
Moat coverage
Shared moat types
Novo Nordisk A/S strengths
TransUnion strengths
Segment mix
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
TransUnion segments
Full profile >U.S. Markets - Financial Services
Oligopoly
U.S. Markets - Emerging Verticals
Competitive
U.S. Markets - Consumer Interactive
Competitive
International
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.